Study type

Study topic

Other

Study topic, other

Disease/Epidemiology study

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Drug utilisation

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Cohort
Population studied

Short description of the study population

Persons 18 years of age or older (turned between 2011 and 2018) who have at least least one prescription or dispensing of an opioid registered in the Pharmaceutical provision information system (GAIA) of SVS Data Warehouse.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Renal impaired
Hepatic impaired
Immunocompromised
Pregnant women

Estimated number of subjects

150000
Study design details

Main study objective

To create a cohort of patients initiating with opioids in the region of Valencia to study:- indicence and prevalence of use of opioids and the impact of the june 2018 informative note of the AEMPS (objectives funded by Grunenthal)- appropiateness of prescription and management of episodes, and the relation between treatment duration and opiod-related events (not funded by Grunenthal)

Data analysis plan

Baseline characteristics will be described, total and stratified by type of pain (oncologic, chronic non-oncologic, other) and duration of treatment. Proportion of inappropiate prescription will be provided using several indicators. Use of healthcare resources in the year following start on opiods will be accounted. Crude and standardized use rates and time series will be constructed to picture evolution of use. Interrupted time serie analysis will be used to assess the impact of 2008 AEMPS note, using Prais-Winsten models with Cochrane-Orcutt transformation and Durbin-Watson test to assess autocorrelation correction. Multilevel regression analysis will be used to assess the association between treatment duration and opiod-related events, with patient factors in first level, basic health zone in second and health department in third level.
Documents
Study, other information
English (1.44 MB - PDF)View document
English (101.1 KB - PDF)View document